Home › Hidradenitis Suppurativa › Tennessee
Hidradenitis Suppurativa clinical trials in Tennessee
3 studies for Hidradenitis Suppurativa are looking for participants at sites in Tennessee.
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Smyrna
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Oct 29, 2026 · NCT07783542A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Site 125, Nashville
- Site 118, Smyrna
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 7, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07828860From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.